🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT07811492
Active, not recruiting Observational

CIRCA-MED WP1 & WP3 - Circadian Rhythms in ICU Patients

NCT07811492 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2025-10-01
Last updated
2026-09-10

Condition(s) studied

Circadian Rhythm

Investigational drug(s) / intervention(s)

Exposure to routine clinical parametersExposure to ICU clinical factors and treatmentsExposure to critical illness-related conditionsExposure to molecular and hormonal circadian markersExposure to metabolic changes related to critical illness

Exposure to routine clinical parameters: These are the primary exposures and are used to detect oscillatory patterns and characterize circadian rhythms. They include heart rate, body temperature, blood pressure, blood glucose, and insulin.

Exposure to ICU clinical factors and treatments: These are secondary exposures that may influence circadian rhythms: illness severity (e.g., Sequential Organ Failure Assessment (SOFA) score), sedation levels, organ support therapies (e.g., ventilation, dialysis, Extracorporeal Membrane Oxygenation (ECMO)), and medications administered during ICU stay (e.g., sedatives, vasopressors, corticosteroids).

Exposure to critical illness-related conditions: These exposures represent complications that may be associated with circadian disruption: delirium, deep sedation, ICU-acquired muscle weakness, and post-intensive care syndrome.

Exposure to molecular and hormonal circadian markers: These exposures reflect biological clock function: clock gene expression (if available in some cases), and melatonin levels.

Exposure to metabolic changes related to critical illness: These exposures represent metabolic consequences of critical illness: insulin sensitivity, muscle atrophy, and critical illness myopathy or ICU-acquired weakness.

Study summary

The goal of this retrospective exploratory study is to examine how the body's natural day-and-night rhythms and oscillatory patterns behave in people who were treated in the Intensive Care Unit (ICU). The study uses routine clinical data that were already collected during and after the ICU stay, including post-discharge follow-up measurements (where available), such as heart rate, temperature, blood pressure, blood sugar, and insulin. The researchers want to learn whether these measurements show daily patterns and whether patients can be grouped based on their oscillatory profiles. The study also examines whether certain clinical factors such as illness severity scores, sedation levels, organ support treatments, or medications are associated with changes in these oscillatory rhythms. The team will explore whether conditions that can develop during or after critical illness, such as delirium, muscle weakness, or Post-Intensive Care Syndrome (PICS), are linked to disturbed physiological rhythms. Another goal is to test whether it is technically possible to show a patient's rhythm profile in real time using routine data from the ICU information system, evaluated retrospectively. Digital tools called "Chrono-Apps" will be developed to display rhythmic information and may help clinicians adjust lighting to patient needs.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: Primary Retrospective Cohort: * Admitted to and treated in a participating Intensive Care Unit (ICU) between 2017 and 2024 * Minimum ICU length of stay of 3 days (≥ 72 hours) * Age ≥ 18 years at the time of ICU admission * All genders (male, female, diverse) Cohorts from previous studies: * Prior enrollment in one of the designated parent study protocols * Availability of supplementary biological or metabolic data (e.g., clock gene expression, melatonin levels) suitable for exploratory association analyses Exclusion Criteria: * None

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Institute of Medical Informatics, Charite University, Berlin Berlin Germany

More Charite University, Berlin, Germany trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07811492 on ClinicalTrials.gov ↗ ← All trials in Germany